Thomas D Schmittgen, PhD
College of Pharmacy
Pharmaceutical Chemistra / Pharmaceutics
Molecular Biology and Cancer Genetics
Neoplasms, Carcinoma, Hepatocellular, Liver Neoplasms, Pancreatic Neoplasms, Urinary Bladder Neoplasms, Adenocarcinoma, Cholangiocarcinoma, Carcinoma, Transitional Cell, Prostatic Neoplasms, Down Syndrome
Dr. Schmittgen's research interests are Quantitative gene expression analysis and the role of small, noncoding (i.e. micro RNAs) in cancer.